-
1
-
-
77958502639
-
Chemotherapy of human African trypanosomiasis
-
Bacchi CJ. 2009. Chemotherapy of human African trypanosomiasis. Interdiscip. Perspect. Infect. Dis. 2009:195040.
-
(2009)
Interdiscip. Perspect. Infect. Dis.
, vol.2009
, pp. 195040
-
-
Bacchi, C.J.1
-
2
-
-
61449194280
-
Infectious diseases of the nervous system and their impact in developing countries
-
doi:10.1371/journal.ppat.1000199
-
Bruzzone R, Dubois-Dalcq M, Grau GE, Griffin DE, Kristensson K. 2009. Infectious diseases of the nervous system and their impact in developing countries. PLoS Pathog. 5:e1000199. doi:10.1371/journal.ppat .1000199.
-
(2009)
PLoS Pathog.
, vol.5
-
-
Bruzzone, R.1
Dubois-Dalcq, M.2
Grau, G.E.3
Griffin, D.E.4
Kristensson, K.5
-
3
-
-
34548484157
-
Migration of African trypanosomes across the blood-brain barrier
-
Masocha W, Rottenberg ME, Kristensson K. 2007. Migration of African trypanosomes across the blood-brain barrier. Physiol. Behav. 92:110-114.
-
(2007)
Physiol. Behav.
, vol.92
, pp. 110-114
-
-
Masocha, W.1
Rottenberg, M.E.2
Kristensson, K.3
-
4
-
-
84861909705
-
Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis
-
Simarro PP, Franco J, Diarra A, Postigo JA, Jannin J. 2012. Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis. Parasitology 139:842-846.
-
(2012)
Parasitology
, vol.139
, pp. 842-846
-
-
Simarro, P.P.1
Franco, J.2
Diarra, A.3
Postigo, J.A.4
Jannin, J.5
-
5
-
-
78650306664
-
Chemotherapy against human african trypanosomiasis: Is there a road to success?
-
Burri C. 2010. Chemotherapy against human African trypanosomiasis: Is there a road to success? Parasitology 137:1987-1994.
-
(2010)
Parasitology
, vol.137
, pp. 1987-1994
-
-
Burri, C.1
-
7
-
-
81555200525
-
Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness
-
Kaiser M, Ma Bray Cal M, Bourdin Trunz B, Torreele E, Brun R. 2011. Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness. Antimicrob. Agents Chemother. 55:5602-5608.
-
(2011)
Antimicrob. Agents Chemother.
, vol.55
, pp. 5602-5608
-
-
Kaiser, M.1
Ma Bray Cal, M.2
Bourdin Trunz, B.3
Torreele, E.4
Brun, R.5
-
8
-
-
70449507450
-
Preclinical assessment of the treatment of second-stage African trypanosomiasis with cordycepin and deoxycoformycin
-
doi:10.1371/journal.pntd.0000495
-
Vodnala SK, Ferella M, Lundén-Miguel H, Betha E, van Reet N, Amin DN, Oberg B, Andersson B, Kristensson K, Wigzell H, Rottenberg ME. 2009. Preclinical assessment of the treatment of second-stage African trypanosomiasis with cordycepin and deoxycoformycin. PLoS Negl. Trop. Dis. 3:e495. doi:10.1371/journal.pntd.0000495.
-
(2009)
PLoS Negl. Trop. Dis.
, vol.3
-
-
Vodnala, S.K.1
Ferella, M.2
Lundén-Miguel, H.3
Betha, E.4
Van Reet, N.5
Amin, D.N.6
Oberg, B.7
Andersson, B.8
Kristensson, K.9
Wigzell, H.10
Rottenberg, M.E.11
-
9
-
-
77950406212
-
Nmyristoyltransferase inhibitors as new leads to treat sleeping sickness
-
Frearson JA, Brand S, McElroy SP, Cleghorn LA, Smid O, Stojanovski L, Price HP, Guther ML, Torrie LS, Robinson DA, Hallyburton I, Mpamhanga CP, Brannigan JA, Wilkinson AJ, Hodgkinson M, Hui R, Qiu W, Raimi OG, van Aalten DM, Brenk R, Gilbert IH, Read KD, Fairlamb AH, Ferguson MA, Smith DF, Wyatt PG. 2010. Nmyristoyltransferase inhibitors as new leads to treat sleeping sickness. Nature 464:728-732.
-
(2010)
Nature
, vol.464
, pp. 728-732
-
-
Frearson, J.A.1
Brand, S.2
McElroy, S.P.3
Cleghorn, L.A.4
Smid, O.5
Stojanovski, L.6
Price, H.P.7
Guther, M.L.8
Torrie, L.S.9
Robinson, D.A.10
Hallyburton, I.11
Mpamhanga, C.P.12
Brannigan, J.A.13
Wilkinson, A.J.14
Hodgkinson, M.15
Hui, R.16
Qiu, W.17
Raimi, O.G.18
Van Aalten, D.M.19
Brenk, R.20
Gilbert, I.H.21
Read, K.D.22
Fairlamb, A.H.23
Ferguson, M.A.24
Smith, D.F.25
Wyatt, P.G.26
more..
-
10
-
-
79952477411
-
2,4-Diaminopyrimidines as potent inhibitors of Trypanosoma brucei and identification of molecular targets by a chemical proteomics approach
-
doi:10 .1371/journal.pntd.0000956
-
Mercer L, Bowling T, Perales J, Freeman J, Nguyen T, Bacchi C, Yarlett N, Don R, Jacobs R, Nare B. 2011. 2,4-Diaminopyrimidines as potent inhibitors of Trypanosoma brucei and identification of molecular targets by a chemical proteomics approach. PLoS Negl. Trop. Dis. 5:e956. doi:10 .1371/journal.pntd. 0000956.
-
(2011)
PLoS Negl. Trop. Dis.
, vol.5
-
-
Mercer, L.1
Bowling, T.2
Perales, J.3
Freeman, J.4
Nguyen, T.5
Bacchi, C.6
Yarlett, N.7
Don, R.8
Jacobs, R.9
Nare, B.10
-
11
-
-
79953838369
-
Detection of group 1 Trypanosoma brucei gambiense by loop-mediated isothermal amplification
-
Njiru ZK, Traub R, Ouma JO, Enyaru JC, Matovu E. 2011. Detection of group 1 Trypanosoma brucei gambiense by loop-mediated isothermal amplification. J. Clin. Microbiol. 49:1530-1536.
-
(2011)
J. Clin. Microbiol.
, vol.49
, pp. 1530-1536
-
-
Njiru, Z.K.1
Traub, R.2
Ouma, J.O.3
Enyaru, J.C.4
Matovu, E.5
-
12
-
-
0036840994
-
Direct detection and identification of African trypanosomes by fluorescence in situ hybridization with peptide nucleic acid probes
-
Radwanska M, Magez S. 2002. Direct detection and identification of African trypanosomes by fluorescence in situ hybridization with peptide nucleic acid probes. J. Clin. Microbiol. 40:4295-4297.
-
(2002)
J. Clin. Microbiol.
, vol.40
, pp. 4295-4297
-
-
Radwanska, M.1
Magez, S.2
-
13
-
-
70449568251
-
Bioluminescent imaging of Trypanosoma brucei shows preferential testis dissemination which may hamper drug efficacy in sleeping sickness
-
doi:10.1371/journal.pntd.0000486
-
Claes F, Vodnala SK, van Reet N, Boucher N, Lunden-Miguel H, Baltz T, Goddeeris BM, Büscher P, Rottenberg ME. 2009. Bioluminescent imaging of Trypanosoma brucei shows preferential testis dissemination which may hamper drug efficacy in sleeping sickness. PLoS Negl. Trop. Dis. 3:e486. doi:10.1371/journal.pntd.0000486.
-
(2009)
PLoS Negl. Trop. Dis.
, vol.3
-
-
Claes, F.1
Vodnala, S.K.2
Van Reet, N.3
Boucher, N.4
Lunden-Miguel, H.5
Baltz, T.6
Goddeeris, B.M.7
Büscher, P.8
Rottenberg, M.E.9
-
14
-
-
0028988032
-
A novel cultivation technique for long-term maintenance of bloodstream form trypanosomes in vitro
-
Hesse F, Selzer PM, Mühlstädt K, Duszenko M. 1995. A novel cultivation technique for long-term maintenance of bloodstream form trypanosomes in vitro. Mol. Biochem. Parasitol. 70:157-166.
-
(1995)
Mol. Biochem. Parasitol.
, vol.70
, pp. 157-166
-
-
Hesse, F.1
Selzer, P.M.2
Mühlstädt, K.3
Duszenko, M.4
-
15
-
-
84872867379
-
Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor
-
May
-
Nilsson B. May 2002. Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor. US patent WO0240456A1.
-
(2002)
US Patent WO0240456A1
-
-
Nilsson, B.1
-
16
-
-
55749099657
-
Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding
-
Waters NJ, Jones R, Williams G, Sohal B. 2008. Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding. J. Pharmaceut. Sci. 97:4586-4595.
-
(2008)
J. Pharmaceut. Sci.
, vol.97
, pp. 4586-4595
-
-
Waters, N.J.1
Jones, R.2
Williams, G.3
Sohal, B.4
-
17
-
-
0028342648
-
Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance
-
Houston J. 1994. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem. Pharmacol. 47:1469-1479.
-
(1994)
Biochem. Pharmacol.
, vol.47
, pp. 1469-1479
-
-
Houston, J.1
-
18
-
-
38449084547
-
Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers
-
Hubatsch I, Ragnarsson EGE, Artursson P. 2007. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat. Protoc. 2:2111-2119.
-
(2007)
Nat. Protoc.
, vol.2
, pp. 2111-2119
-
-
Hubatsch, I.1
Ragnarsson, E.G.E.2
Artursson, P.3
-
19
-
-
33748636018
-
Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development
-
Baranczewski P, Stań czak A, Sundberg K, Svensson R, Wallin A, Jansson J, Garberg P, Postlind H. 2006. Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. Pharmacol. Rep. 58:453-472.
-
(2006)
Pharmacol. Rep.
, vol.58
, pp. 453-472
-
-
Baranczewski, P.1
Stańczak, A.2
Sundberg, K.3
Svensson, R.4
Wallin, A.5
Jansson, J.6
Garberg, P.7
Postlind, H.8
-
20
-
-
60749084392
-
Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes
-
Balasegaram M, Young H, Chappuis F, Priotto G, Raguenaud M-E, Checchi F. 2009. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes. Trans R Soc. Trop. Med. Hyg. 103:280-290.
-
(2009)
Trans R Soc. Trop. Med. Hyg.
, vol.103
, pp. 280-290
-
-
Balasegaram, M.1
Young, H.2
Chappuis, F.3
Priotto, G.4
Raguenaud, M.-E.5
Checchi, F.6
-
21
-
-
34548702901
-
Melarsoprol-and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance
-
Bernhard SC, Nerima B, Mäser P, Brun R. 2007. Melarsoprol-and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance. Int. J. Parasitol. 37:1443-1448.
-
(2007)
Int. J. Parasitol.
, vol.37
, pp. 1443-1448
-
-
Bernhard, S.C.1
Nerima, B.2
Mäser, P.3
Brun, R.4
-
22
-
-
84855848964
-
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors
-
Brand S, Cleghorn LA, McElroy SP, Robinson DA, Smith VC, Hallyburton I, Harrison JR, Norcross NR, Spinks D, Bayliss T, Norval S, Stojanovski L, Torrie LS, Frearson JA, Brenk R, Fairlamb AH, Ferguson MA, Read KD, Wyatt PG, Gilbert IH. 2012. Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors. J. Med. Chem. 55:140-152.
-
(2012)
J. Med. Chem.
, vol.55
, pp. 140-152
-
-
Brand, S.1
Cleghorn, L.A.2
McElroy, S.P.3
Robinson, D.A.4
Smith, V.C.5
Hallyburton, I.6
Harrison, J.R.7
Norcross, N.R.8
Spinks, D.9
Bayliss, T.10
Norval, S.11
Stojanovski, L.12
Torrie, L.S.13
Frearson, J.A.14
Brenk, R.15
Fairlamb, A.H.16
Ferguson, M.A.17
Read, K.D.18
Wyatt, P.G.19
Gilbert, I.H.20
more..
-
23
-
-
84861212906
-
Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs
-
doi:10.1371/journal.pntd.0001625
-
Bell AS, Mills JE, Williams GP, Brannigan JA, Wilkinson AJ, Parkinson T, Leatherbarrow RJ, Tate EW, Holder AA, Smith DF. 2012. Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs. PLoS Negl. Trop. Dis. 6:e1625. doi:10.1371/journal.pntd.0001625.
-
(2012)
PLoS Negl. Trop. Dis.
, vol.6
-
-
Bell, A.S.1
Mills, J.E.2
Williams, G.P.3
Brannigan, J.A.4
Wilkinson, A.J.5
Parkinson, T.6
Leatherbarrow, R.J.7
Tate, E.W.8
Holder, A.A.9
Smith, D.F.10
-
24
-
-
79959787951
-
SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis
-
doi:10.1371/journal.pntd.0001151
-
Jacobs RT, Nare B, Wring SA, Orr MD, Chen D, Sligar JM, Jenks MX, Noe RA, Bowling TS, Mercer LT, Rewerts C, Gaukel E, Owens J, Parham R, Randolph R, Beaudet B, Bacchi CJ, Yarlett N, Plattner JJ, Freund Y, Ding C, Akama T, Zhang Y-K, Brun R, Kaiser M, Scandale I, Don R. 2011. SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis. PLoS Negl. Trop. Dis. 5:e1151. doi:10.1371/journal.pntd.0001151.
-
(2011)
PLoS Negl. Trop. Dis.
, vol.5
-
-
Jacobs, R.T.1
Nare, B.2
Wring, S.A.3
Orr, M.D.4
Chen, D.5
Sligar, J.M.6
Jenks, M.X.7
Noe, R.A.8
Bowling, T.S.9
Mercer, L.T.10
Rewerts, C.11
Gaukel, E.12
Owens, J.13
Parham, R.14
Randolph, R.15
Beaudet, B.16
Bacchi, C.J.17
Yarlett, N.18
Plattner, J.J.19
Freund, Y.20
Ding, C.21
Akama, T.22
Zhang, Y.-K.23
Brun, R.24
Kaiser, M.25
Scandale, I.26
Don, R.27
more..
-
25
-
-
78650682602
-
Fexinidazole-A new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness
-
doi:10.1371/journal.pntd.0000923
-
Torreele E, Bourdin Trunz B, Tweats D, Kaiser M, Brun R, MazuÉ G, Bray MA, Pécoul B. 2010. Fexinidazole-a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness. PLoS Negl. Trop. Dis. 4:e923. doi:10.1371/journal.pntd.0000923.
-
(2010)
PLoS Negl. Trop. Dis.
, vol.4
-
-
Torreele, E.1
Bourdin Trunz, B.2
Tweats, D.3
Kaiser, M.4
Brun, R.5
MazuÉ, G.6
Bray, M.A.7
Pécoul, B.8
|